Activation and inhibition of the C-terminal kinase domain of p90 ribosomal S6 kinases

Marlene Uglebjerg Fruergaard, Christine Juul Fælled Nielsen, Cecilia Rosada Kjeldsen, Lars Iversen, Jacob Lauwring Andersen, Poul Nissen

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Abstract

The p90 ribosomal S6 kinases (RSKs) contain two distinct catalytic kinase domains, the N-terminal and C-terminal kinase domains (NTKD and CTKD, respectively). The activation of CTKD is regulated by phosphorylation by extracellular signal-regulated kinase (ERK1/2) and an autoinhibitory αL helix. Through a mutational series in vitro of the RSK CTKDs, we found a complex mechanism lifting autoinhibition that led us to design constitutively active RSK CTKDs. These are based on a phosphomimetic mutation and a C-terminal truncation (e.g., RSK2 T577E D694*) where a high activity in absence of ERK phosphorylation is obtained. Using these constructs, we characterize IC50 values of ATP-competitive inhibitors and provide a setup for determining specificity constants (kinact/Ki) of covalent CTKD inhibitors.

OriginalsprogEngelsk
Artikelnummere202201425
TidsskriftLife science alliance
Vol/bind6
Nummer5
ISSN2575-1077
DOI
StatusUdgivet - maj 2023

Fingeraftryk

Dyk ned i forskningsemnerne om 'Activation and inhibition of the C-terminal kinase domain of p90 ribosomal S6 kinases'. Sammen danner de et unikt fingeraftryk.

Citationsformater